Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Redfield

Showing results (881-890 of 1,078) with videos related to

Pageof 108
Sort By:
Kidney360|April 4, 2022
Oxidized-ATP Attenuates Kidney Allograft Rejection By Inhibiting T-Cell, B-Cell, and Macrophage ActivityXiang Ding, Nancy A Wilson, Robert R Redfield, et al.
European Journal of Heart Failure|September 19, 2018
Is mild asymptomatic left ventricular systolic dysfunction always predictive of adverse events in high-risk populations? Insights from the DAVID-Berg studyMauro Gori, Margaret M Redfield, Alice Calabrese, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 6, 2022
An intervention strategy to improve genetic testing for dilated cardiomyopathy in a heart failure clinicAkanksha Mohananey, Andrew S Tseng, Raghav R Julakanti, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 28, 2017
Experimental cardiac radiation exposure induces ventricular diastolic dysfunction with preserved ejection fractionHirofumi Saiki, Gilles Moulay, Adam J Guenzel, et al.
Antiviral Therapy|December 22, 2018
Disparate effects of cytotoxic chemotherapy on the antiviral activity of antiretroviral therapy: implications for treatments of HIV-infected cancer patientsSandra Medina-Moreno, Juan C Zapata, Mackenzie L Cottrell, et al.
Circulation. Heart Failure|October 29, 2013
Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary studyRosita Zakeri, Barry A Borlaug, Steven E McNulty, et al.
JACC. Cardiooncology|January 29, 2021
A Proteomic Atlas of Cardiac Amyloid PlaquesTaxiarchis V Kourelis, Surendra S Dasari, Angela Dispenzieri, et al.
Hypertension (Dallas, Tex. : 1979)|April 22, 2015
Circulating C-type natriuretic peptide and its relationship to cardiovascular disease in the general populationS Jeson Sangaralingham, Paul M McKie, Tomoko Ichiki, et al.
Journal of the American Heart Association|February 20, 2017
Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection FractionOmar F AbouEzzeddine, Paul M McKie, Shannon M Dunlay, et al.
Human Gene Therapy|December 1, 1994
Consequences of stable transduction and antigen-inducible expression of the human interleukin-7 gene on tetanus-toxoid-specific T cellsJ H Kim, S Ratto, K V Sitz, et al.
Pageof 108

Showing results (881-890 of 1,078) with videos related to

Sort By:
Pageof 108
Kidney360|April 4, 2022
Oxidized-ATP Attenuates Kidney Allograft Rejection By Inhibiting T-Cell, B-Cell, and Macrophage ActivityXiang Ding, Nancy A Wilson, Robert R Redfield, et al.
European Journal of Heart Failure|September 19, 2018
Is mild asymptomatic left ventricular systolic dysfunction always predictive of adverse events in high-risk populations? Insights from the DAVID-Berg studyMauro Gori, Margaret M Redfield, Alice Calabrese, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 6, 2022
An intervention strategy to improve genetic testing for dilated cardiomyopathy in a heart failure clinicAkanksha Mohananey, Andrew S Tseng, Raghav R Julakanti, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 28, 2017
Experimental cardiac radiation exposure induces ventricular diastolic dysfunction with preserved ejection fractionHirofumi Saiki, Gilles Moulay, Adam J Guenzel, et al.
Antiviral Therapy|December 22, 2018
Disparate effects of cytotoxic chemotherapy on the antiviral activity of antiretroviral therapy: implications for treatments of HIV-infected cancer patientsSandra Medina-Moreno, Juan C Zapata, Mackenzie L Cottrell, et al.
Circulation. Heart Failure|October 29, 2013
Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary studyRosita Zakeri, Barry A Borlaug, Steven E McNulty, et al.
JACC. Cardiooncology|January 29, 2021
A Proteomic Atlas of Cardiac Amyloid PlaquesTaxiarchis V Kourelis, Surendra S Dasari, Angela Dispenzieri, et al.
Hypertension (Dallas, Tex. : 1979)|April 22, 2015
Circulating C-type natriuretic peptide and its relationship to cardiovascular disease in the general populationS Jeson Sangaralingham, Paul M McKie, Tomoko Ichiki, et al.
Journal of the American Heart Association|February 20, 2017
Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection FractionOmar F AbouEzzeddine, Paul M McKie, Shannon M Dunlay, et al.
Human Gene Therapy|December 1, 1994
Consequences of stable transduction and antigen-inducible expression of the human interleukin-7 gene on tetanus-toxoid-specific T cellsJ H Kim, S Ratto, K V Sitz, et al.
Pageof 108